BIMERGEN ENERGY CORP (BESS) Fundamental Analysis & Valuation

NYSEARCA:BESS • US84856X2053

Current stock price

2.5 USD
-0.01 (-0.4%)
At close:
2.55 USD
+0.05 (+2%)
After Hours:

This BESS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BESS Profitability Analysis

1.1 Basic Checks

  • In the past year BESS has reported negative net income.
  • BESS had a positive operating cash flow in the past year.
BESS Yearly Net Income VS EBIT VS OCF VS FCFBESS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -1M -2M -3M -4M

1.2 Ratios

  • BESS's Return On Assets of -18.28% is in line compared to the rest of the industry. BESS outperforms 46.74% of its industry peers.
  • With a Return On Equity value of -25.68%, BESS perfoms like the industry average, outperforming 53.26% of the companies in the same industry.
Industry RankSector Rank
ROA -18.28%
ROE -25.68%
ROIC N/A
ROA(3y)-175.63%
ROA(5y)N/A
ROE(3y)-223.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BESS Yearly ROA, ROE, ROICBESS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 -200 -400 -600

1.3 Margins

  • BESS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BESS Yearly Profit, Operating, Gross MarginsBESS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 -50K -100K -150K -200K -250K

2

2. BESS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BESS has been reduced compared to 1 year ago.
  • BESS has a worse debt/assets ratio than last year.
BESS Yearly Shares OutstandingBESS Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 1M 2M 3M 4M 5M
BESS Yearly Total Debt VS Total AssetsBESS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • BESS has an Altman-Z score of 0.06. This is a bad value and indicates that BESS is not financially healthy and even has some risk of bankruptcy.
  • BESS has a Altman-Z score (0.06) which is comparable to the rest of the industry.
  • BESS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.04, BESS is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.06
ROIC/WACCN/A
WACCN/A
BESS Yearly LT Debt VS Equity VS FCFBESS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 0.42 indicates that BESS may have some problems paying its short term obligations.
  • BESS has a Current ratio of 0.42. This is amonst the worse of the industry: BESS underperforms 89.13% of its industry peers.
  • A Quick Ratio of 0.42 indicates that BESS may have some problems paying its short term obligations.
  • BESS has a worse Quick ratio (0.42) than 83.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
BESS Yearly Current Assets VS Current LiabilitesBESS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 2M 4M 6M

0

3. BESS Growth Analysis

3.1 Past

  • The earnings per share for BESS have decreased strongly by -106.99% in the last year.
EPS 1Y (TTM)-106.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BESS Yearly Revenue VS EstimatesBESS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 50 100 150 200 250

0

4. BESS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BESS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BESS Price Earnings VS Forward Price EarningsBESS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BESS Per share dataBESS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. BESS Dividend Analysis

5.1 Amount

  • BESS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BESS Fundamentals: All Metrics, Ratios and Statistics

BIMERGEN ENERGY CORP

NYSEARCA:BESS (5/1/2026, 8:11:18 PM)

After market: 2.55 +0.05 (+2%)

2.5

-0.01 (-0.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Industry Strength94.41
Industry Growth57.76
Earnings (Last)03-31
Earnings (Next)06-08
Inst Owners9.9%
Inst Owner Change0%
Ins Owners37.81%
Ins Owner ChangeN/A
Market Cap17.68M
Revenue(TTM)N/A
Net Income(TTM)-4.97M
AnalystsN/A
Price TargetN/A
Short Float %0.35%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF 20.12
P/B 0.91
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)0.12
OCFY4.97%
SpS0
BVpS2.74
TBVpS-0.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -18.28%
ROE -25.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-175.63%
ROA(5y)N/A
ROE(3y)-223.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 0.06
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-128.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y351.12%
OCF growth 3YN/A
OCF growth 5YN/A

BIMERGEN ENERGY CORP / BESS Fundamental Analysis FAQ

What is the fundamental rating for BESS stock?

ChartMill assigns a fundamental rating of 1 / 10 to BESS.


What is the valuation status of BIMERGEN ENERGY CORP (BESS) stock?

ChartMill assigns a valuation rating of 0 / 10 to BIMERGEN ENERGY CORP (BESS). This can be considered as Overvalued.


Can you provide the profitability details for BIMERGEN ENERGY CORP?

BIMERGEN ENERGY CORP (BESS) has a profitability rating of 1 / 10.


Can you provide the financial health for BESS stock?

The financial health rating of BIMERGEN ENERGY CORP (BESS) is 2 / 10.